NOAEL Studies
Cosmetic Ingredient
Tetraaminopyrimidine Sulfate NOAEL Studies
INCI: TETRAAMINOPYRIMIDINE SULFATE
CAS: 5392-28-9
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
NTP ICE eye irritation 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| NTP ICE eye irritation | EPA Classification | 3 | unitless | Rabbit | Ocular | - | In Vivo; Draize Eye Irritation/Corrosion Test | sheet=Data; excel_row=388; Record_ID=eye_irritation_96; Data_Type=In Vivo; Concentration=100.0; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID0037023; Assay=Draize Eye Irritation/Corrosion Test; Endpoint=EPA Classification; Response=3; Response_Unit=Unitless; Species=Rabbit; Reference=ICCVAM 2006; URL=https://ntp.niehs.nih.gov/sites/default/files/iccvam/docs/ocutox_docs/oteval/otevalrpt.pdf; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID0037023 |
SCCS Opinion 6 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =28 | - | - | - | 28 days | NOAEL study | p.14 |
| SCCS Opinion | NOAEL | =150 | mg/kg bw/d | rat | oral | 90-day | repeated dose toxicity | p.15 |
| SCCS Opinion | NOAEL | =375 | mg/kg/d | rat | dermal | - | developmental toxicity | p.20 |
| SCCS Opinion | NOAEL | =375 | mg/kg bw/day | rat | oral | subchronic | repeated dose toxicity | p.24 |
| SCCS Opinion | NOAEL | =500 | mg/kg bw | human | oral | sub-chronic | repeated dose toxicity | p.5 |
| SCCS Opinion | NOAEL | =600 | mg/kg bw | human | oral | sub-chronic | repeated dose toxicity | p.5 |
Regulatory source 6 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | 28 | - | - | - | 28 days | - | p.14 |
| Regulatory source | developmental toxicity | 375 | mg/kg/d | rat | dermal | - | developmental toxicity | p.20 |
| Regulatory source | repeated dose toxicity | 150 | mg/kg bw/d | rat | oral | 90-day | repeated dose toxicity | p.15 |
| Regulatory source | repeated dose toxicity | 375 | mg/kg bw/day | rat | oral | subchronic | repeated dose toxicity | p.24 |
| Regulatory source | repeated dose toxicity | 500 | mg/kg bw | human | oral | sub-chronic | repeated dose toxicity | p.5 |
| Regulatory source | repeated dose toxicity | 600 | mg/kg bw | human | oral | sub-chronic | repeated dose toxicity | p.5 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | 53QQY0I99M | UNII | - | - | - | chemical | - |